Related Experiment Video
Updated: Dec 29, 2025

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Sunscreen products: Rationale for use, formulation development and regulatory considerations
Kiriiri Geoffrey1, A N Mwangi1, S M Maru1
1Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, P.O Box 19676-00202, Nairobi, Kenya.
Abstract:
The association of sunrays with skin damage have been known since medieval times. The description of the electromagnetic spectrum facilitated the identification of the ultraviolet light spectrum as being responsible for skin damage resulting from prolonged skin exposure. Sunscreens have been used since ancient civilizations with various measures to limit exposure to sun exposure being employed. Awareness of the risks associated with sunrays has been increasing in the last century, and as a result, the science, technologies, and formulation have advanced significantly. The use of sunscreen products continues rising as government health agencies seek to contain increasing cases of UV induced melanomas. Recreational sunbathing and artificial tanning have increased the risk for these diseases significantly. This review article sought to expound the scientific basis of sunscreen use, the classification, formulation, quality control and regulation across the different countries around the world. The literature review was conducted on Google scholar, PubMed, SCOPUS, Cochrane, BMJ, SCIELO among others.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment
Drug Regulation
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence studies: Biowaivers

